BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20690096)

  • 1. Activation of the endogenous coagulation system in patients with atrial flutter: relationship to echocardiographic markers of thromboembolic risk.
    Kamath GS; Herweg B; Cotiga D; Pierce W; Cohen AJ; Chaudhry FA; Drejka ML; Steinberg JS
    Cardiol J; 2010; 17(4):390-6. PubMed ID: 20690096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercoagulability and chronic atrial fibrillation: the role of markers of thrombin generation.
    Soncini M; Casazza F; Mattioli R; Bonfardeci C; Motta A; Cimminiello C
    Minerva Med; 1997 Dec; 88(12):501-5. PubMed ID: 9540779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.
    Tóth NK; Csanádi Z; Hajas O; Kiss A; Nagy-Baló E; Kovács KB; Sarkady F; Muszbek L; Bereczky Z; Csiba L; Bagoly Z
    Biomed Res Int; 2017; 2017():3678017. PubMed ID: 28713823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure.
    Asmarats L; O'Hara G; Champagne J; Paradis JM; Bernier M; O'Connor K; Beaudoin J; Junquera L; Del Val D; Muntané-Carol G; Côté M; Rodés-Cabau J
    Circ Cardiovasc Interv; 2020 Aug; 13(8):e009039. PubMed ID: 32772571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation.
    Ammash N; Konik EA; McBane RD; Chen D; Tange JI; Grill DE; Herges RM; McLeod TG; Friedman PA; Wysokinski WE
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2760-6. PubMed ID: 21852562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged activation of hemostatic markers following conversion of atrial flutter to sinus rhythm.
    Sakurai K; Hirai T; Nakagawa K; Kameyama T; Nozawa T; Asanoi H; Inoue H
    Circ J; 2004 Nov; 68(11):1041-4. PubMed ID: 15502386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy.
    Mitusch R; Siemens HJ; Garbe M; Wagner T; Sheikhzadeh A; Diederich KW
    Thromb Haemost; 1996 Feb; 75(2):219-23. PubMed ID: 8815563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation.
    Drabik L; Wołkow P; Undas A
    Thromb Res; 2015 Aug; 136(2):408-14. PubMed ID: 26048399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thromboembolic risk factors in atrial flutter. Transesophageal echocardiographic study].
    Thumala A; Parra C; Maragaño P; Puelma A; Florenzano F
    Rev Med Chil; 2000 Dec; 128(12):1327-34. PubMed ID: 11227241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transvenous cryoablation reduces platelet activation during pulmonary vein ablation compared with radiofrequency energy in patients with atrial fibrillation.
    Tse HF; Kwong YL; Lau CP
    J Cardiovasc Electrophysiol; 2005 Oct; 16(10):1064-70. PubMed ID: 16191116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of inflammatory and hemostatic markers with stroke and thromboembolic events in atrial fibrillation: a systematic review and meta-analysis.
    Wu N; Chen X; Cai T; Wu L; Xiang Y; Zhang M; Li Y; Song Z; Zhong L
    Can J Cardiol; 2015 Mar; 31(3):278-86. PubMed ID: 25746020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke.
    Hyacinth HI; Adams RJ; Greenberg CS; Voeks JH; Hill A; Hibbert JM; Gee BE
    PLoS One; 2015; 10(8):e0134193. PubMed ID: 26305570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Echocardiographic and hematological variables as a risk factor for stroke in chronic nonvalvular atrial fibrillation].
    Uzui H; Lee JD; Shimizu H; Sugiyama T; Nakano A; Hamada T; Ueda T
    J Cardiol; 1998 Jul; 32(1):15-20. PubMed ID: 9739513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypercoagulability in atrial fibrillation and its relationship with risk factors for systemic embolism].
    Pérez LA; Corbalán R; Acevedo M; Pereira J; Braun S; Tapia J; Kramer A; Lira MT; Huete I; Sepúlveda G; Springmüller D
    Rev Med Chil; 2002 Oct; 130(10):1087-94. PubMed ID: 12491825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between flow dynamics in the left atrium and hemostatic abnormalities in patients with nonvalvular atrial fibrillation.
    Shinohara H; Fukuda N; Soeki T; Takeichi N; Yui Y; Tamura Y; Oki T
    Jpn Heart J; 1998 Nov; 39(6):721-30. PubMed ID: 10089934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
    Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
    Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation: prospective five-year follow-up study].
    Enta K; Iwade K; Aosaki M; Uchida T; Kasanuki H
    J Cardiol; 2004 Dec; 44(6):223-32. PubMed ID: 15638220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial appendage function and abnormal hypercoagulability in patients with atrial flutter.
    Sakurai K; Hirai T; Nakagawa K; Kameyama T; Nozawa T; Asanoi H; Inoue H
    Chest; 2003 Nov; 124(5):1670-4. PubMed ID: 14605033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation.
    Heppell RM; Berkin KE; McLenachan JM; Davies JA
    Heart; 1997 May; 77(5):407-11. PubMed ID: 9196408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced thrombogenesis but not platelet activation is associated with transcatheter closure of patent foramen ovale in patients with cryptogenic stroke.
    Bédard E; Rodés-Cabau J; Houde C; Mackey A; Rivest D; Cloutier S; Noël M; Marrero A; Côté JM; Chetaille P; Delisle G; Leblanc MH; Bertrand OF
    Stroke; 2007 Jan; 38(1):100-4. PubMed ID: 17122434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.